Stock Screener App

Frei -

Installieren

14.92

3.40% 0.49

after-market

Handel nachbörslich: 14.93 0.010 +0.07%

Cullinan Therapeutics Inc (CGEM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	0.60% 55.26	55.59	75.80	55.00	48.85
Operating Income/Loss	0.60% -55.26	-55.59	-75.80	-55.00	-48.85
Income/Loss From Continuing Operations Before Tax	0.20% -50.71	-50.61	-70.06	-48.50	-40.56
Income/Loss From Continuing Operations After Tax	0.20% -50.71	-50.61	-70.06	-48.50	-40.56
Net Income/Loss	0.20% -50.71	-50.61	-70.06	-48.50	-40.56
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$48.77

0.87%

ROIV

$27.88

1.59%

RPRX

$47.32

2.57%

BNTX

$91.28

0.11%

ONC

$302.49

2.67%

INSM

$163.81

0.85%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters